GLP‑1 drugs appear to change how much we want to eat, and how strongly food “pulls” on the brain. Newer oral versions may ...

Online health and wellness company Hims & Hers posted a $92 million loss in the first quarter as it transitions its weight loss business to selling branded GLP-1 weight loss treatments, shifting away ...

The FDA has proposed excluding weight-loss drugs, such as Ozempic/Wegovy and Zepbound from a key compounding list, ...

The KDIGO landscape has shifted dramatically since 2012, with the 2024 CKD guidelines introducing over 40 new practice points ...

Miami Gardens Clinic Launches Telehealth Access to Tirzepatide and Semaglutide with Same-Day Appointments.

Amazon said customers can access real-time medication availability, transparent pricing, and same-day delivery. ・Citi previously noted that Amazon’s healthcare model still differs from ...

Hims & Hers launched an artificial intelligence agent embedded in its platform to help interpret biomarker lab results and ...

Researchers have created a next-generation obesity drug that works like a “Trojan horse,” using GLP-1/GIP signals to slip a ...

KELOWNA, BC / / May 5, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in ...

The medication, typically used for weight loss or diabetes treatment, is showing promise curbing cravings for alcohol and ...

Compared with placebo, semaglutide achieved larger reductions in heavy-drinking days (−41.1 vs −26.4 percentage points) and ...

Have a question for Jessica Rendall or our other editors? Ask here for a chance to be featured in a story. Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the ...